MaxLinear (MXL) PT Lowered to $34 at Needham & Company
Get Alerts MXL Hot Sheet
Price: $67.30 -6.02%
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Needham & Company analyst N. Quinn Bolton lowered the price target on MaxLinear (NASDAQ: MXL) to $34.00 (from $48.00) while maintaining a Buy rating.
You May Also Be Interested In
- Evercore ISI Downgrades Reddit (RDDT) to In Line, Removes From Tactical Outperform List
- Regeneron Pharma (REGN) PT Raised to $1,020 at Raymond James
- Encompass Health Corp (EHC) PT Raised to $155 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share